chronic T cell receptor (TCR) signalling, together with sustained LAG3 signalling and other inhibitory receptor signalling, drives T cell dysfunction, highlighting LAG3 as a promising therapeutic targeted immunotherapy in oncology and #autoimmunity
PDF www.nature.com/articles/s41...
